Sponsor
  • ·
  • Chinese Association of
    Integrative Medicine;
    China Academy of Chinese
    Medicine Sciences
Editing
  • ·
  • Editorial Board of
    China Journal of
    Orthopaedics and Traumatology
Publishing
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
Overseas Distributor
  • ·
  • China International Book
    Trading Corporation
    P.O.Box 399,Beijing,China
    Code No.M587
Mail-order
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
    No.16A, Nanxiaojie, Dongzhimennei,
    Beijing 100700,China
    Tel:0086-10-84020925
    Fax:0086-10-84036581
    Http://www.zggszz.com
    E-mail:zggszz@sina.com
骨巨细胞瘤治疗进展
Hits: 1941   Download times: 1462   Received:November 21, 2016    
作者Author单位UnitE-Mail
梁鹏 LIANG Peng 甘肃省肿瘤医院骨与软组织肿瘤科, 甘肃 兰州 730050 Department of Bone and Soft Tissue Tumor, Gansu Cancer Hospital, Lanzhou 730050, Gansu, China  
期刊信息:《中国骨伤》2018年31卷,第3期,第292-296页
DOI:10.3969/j.issn.1003-0034.2018.03.021
骨巨细胞瘤是一种局部具有侵袭性、溶骨活性的良性骨肿瘤,传统治疗手段为囊内刮除植骨,但有很高的局部复发率,通过辅助手段对瘤腔进行处理,有效降低了局部复发;对于不同部位骨巨细胞瘤应依据病变部位、大小、侵犯范围、复发率的高低可选择不同的手术方法,包括假体置换、广泛切除、En-bloc切除等;对于特殊部位预计手术风险大、不能完整切除患者可行动脉栓塞,有利于病情得到控制或手术;双磷酸盐、地诺单抗的应用给骨巨细胞瘤的治疗带来新的希望,可有效降低肿瘤复发,目前主要应用于复发、难治、特殊部位、转移性骨巨细胞瘤的治疗。化疗主要应用于转移、恶性骨巨细胞瘤的治疗,放疗对于复发或难以手术切除部位骨巨细胞瘤可控制肿瘤进展,但有恶变可能。双磷酸盐、地诺单抗缺乏长期随访,远期疗效尚不明确,骨巨细胞瘤治疗领域新方法、新药的研发为其带来了更多希望。
[关键词]:骨巨细胞瘤  外科手术  放化疗,辅助  综述文献
 
Treatment progress on giant cell tumors of bone
Abstract:Giant cell tumors(GCT) of bone is benign bone tumors with aggressive and osteolytic activity. As traditional treatment of GCT,removal of bone graft is disease with high local recurrence rate,and could reduce local recurrence by auxiliary means. Different surgical methods such as prosthesis replacement,wide resection and En-bloc resection could be selected for different parts of giant cell tumor of bone,based on the lesion location,size,extent of invasion,recurrence rate. For patients with special region of GCT of bone with removed incompletely and high surgical risk expected,arterial embolism could be performed. The application of bisphosphonates and denosumab are mainly used in treating recurrent,refractory,special parts,metastatic giant cell tumor of bone will bring new hope of treatment for giant cell tumor of bone,due to lower the recurrence rate. Chemotherapy is mainly used in the treatment of metastasis and malignant bone tumor. Radiotherapy for recurrent or unresectable bone giant cell tumor can control tumor progression,but there is the possibility of malignancy. While long-term follow-up studies and long-term results of applications of bisphosphonates and denosumab are lacking,new methods and development of new drugs are still be needed to treat patients with giant cell tumor of bone and also bring about more hope.
KEYWORDS:Giant cell tumor of bone  Surgical procedure,operative  Chemoradiotherapy,adjuvant  Review literature
 
引用本文,请按以下格式著录参考文献:
中文格式:梁鹏.骨巨细胞瘤治疗进展[J].中国骨伤,2018,31(3):292~296
英文格式:LIANG Peng.Treatment progress on giant cell tumors of bone[J].zhongguo gu shang / China J Orthop Trauma ,2018,31(3):292~296
View Full Text  View/Add Comment  Download reader
Close




版权所有:Editorial Office of China Journal of Orthopaedics and Traumatology京ICP备12048066号  版权声明
地址:No.16A, Nanxiaojie, Dongzhimennei, Beijing 100700, China
电话:0086-10-84036581 传真:0086-10-84036581 Email:zggszz@sina.com